Radware, a well-known supplier of application delivery and cyber security solutions, recently recognised Sycomp as a Signature Partner. Together, the businesses recently closed a $1 million agreement with one of the top 10 biotech firms in the United States. Global provider of cutting-edge data centre, cloud, endpoint, and security services and solutions is Sycomp A Technology Company, Inc.
"We are excited to embark on this journey with Radware as our strategic partner and an industry leader in application and network security,” said Chris Ito, vice president of security sales at Sycomp. “As a Signature Partner, we share in a joint mission with Radware to deliver exceptional solutions and services to customers. Together, we are committed to helping organizations confidently navigate the digital landscape and securely achieve their business objectives.”
“The Signature Partnership is a strong endorsement of the expertise and capabilities that Sycomp brings to the table,” said Yoav Gazelle, Radware’s chief business officer. “Our major win in a highly regulated and competitive industry like biotech is a testament to the strong value proposition we deliver. Our joint customers will benefit from the combined strengths of Sycomp's deep industry knowledge and Radware's state-of-the-art network and application protection and delivery solutions.”
In its search for a DDoS protection system that could fight against volumetric and encrypted attacks as well as automatically neutralise zero-day attacks, the biotech giant chose Radware. The biotech company was also looking for a system with adaptable deployment options to meet the needs of its worldwide on-premises and cloud environment. The biotech company selected Radware's DefensePro® DDoS Protection, Cloud DDoS Protection Service, and Emergency Response Team Service to strengthen its global cyber defences.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
